<p>Healthy controls (n = 60): K<sub>D</sub> = 1.34±0.85 nM; Bmax = 57±46 fmol/mg protein. MTX = methotrexate; RTX = rituximab. Time (t) is expressed as months of pharmacological treatment. Data are expressed as mean ± SD. Differences were considered significant at a value of <i>p</i><0.01 vs healthy controls (*) or vs t = 0 (#).</p
<p>(A): Serum IgD concentrations were significantly different in RA patients (n = 28) and healthy co...
<p>Data are presented as mean ± SEM. *p<0.005, versus active phase, determined by the Wilcoxon signe...
OBJECTIVE: To assess variation in peripheral blood B lymphocyte subsets in rheumatoid arthritis (RA)...
<p>(A) DAS 28 values in RA patients evaluated at different time points of treatment with MTX, anti-T...
<p>(A) A<sub>2A</sub>AR Bmax values in lymphocytes from RA patients evaluated at different time poin...
<p>(A) DAS28 and (B) the absolute number of CD4+CD161+ T-cells from RA patients at baseline (newly d...
Background: Treatment of rheumatoid arthritis (RA) has become more intensive, thereby raising concer...
<p>The RA patients are separated into groups based on DAS response at 4 months. (A) The DAS28 is dep...
<p>Patients were grouped according to the number of fulfilled parameters (corticosteroids therapy, n...
<p>Data are expressed as median [interquartile range].</p>A<p>versus control P<0.05;</p>B<p>versus b...
<p>*Quantitative data are expressed as mean±SD and [range]. CRP, C-reactive protein; DAS28, 28-joint...
<p>A. Surface expression of IL-15 receptor α, β and γ chains on memory B cells from healthy controls...
<p>CD4+ T cells were isolated from the peripheral blood of healthy controls (HCPB) (n = 53), the per...
<p>Graph illustrating T cell, NK and NKT cell populations in healthy controls (N = 15) (▴), patients...
<p>a). Patients were segregated based on low and high microarray IFN scores (<−6.5 and>−4.5) and bas...
<p>(A): Serum IgD concentrations were significantly different in RA patients (n = 28) and healthy co...
<p>Data are presented as mean ± SEM. *p<0.005, versus active phase, determined by the Wilcoxon signe...
OBJECTIVE: To assess variation in peripheral blood B lymphocyte subsets in rheumatoid arthritis (RA)...
<p>(A) DAS 28 values in RA patients evaluated at different time points of treatment with MTX, anti-T...
<p>(A) A<sub>2A</sub>AR Bmax values in lymphocytes from RA patients evaluated at different time poin...
<p>(A) DAS28 and (B) the absolute number of CD4+CD161+ T-cells from RA patients at baseline (newly d...
Background: Treatment of rheumatoid arthritis (RA) has become more intensive, thereby raising concer...
<p>The RA patients are separated into groups based on DAS response at 4 months. (A) The DAS28 is dep...
<p>Patients were grouped according to the number of fulfilled parameters (corticosteroids therapy, n...
<p>Data are expressed as median [interquartile range].</p>A<p>versus control P<0.05;</p>B<p>versus b...
<p>*Quantitative data are expressed as mean±SD and [range]. CRP, C-reactive protein; DAS28, 28-joint...
<p>A. Surface expression of IL-15 receptor α, β and γ chains on memory B cells from healthy controls...
<p>CD4+ T cells were isolated from the peripheral blood of healthy controls (HCPB) (n = 53), the per...
<p>Graph illustrating T cell, NK and NKT cell populations in healthy controls (N = 15) (▴), patients...
<p>a). Patients were segregated based on low and high microarray IFN scores (<−6.5 and>−4.5) and bas...
<p>(A): Serum IgD concentrations were significantly different in RA patients (n = 28) and healthy co...
<p>Data are presented as mean ± SEM. *p<0.005, versus active phase, determined by the Wilcoxon signe...
OBJECTIVE: To assess variation in peripheral blood B lymphocyte subsets in rheumatoid arthritis (RA)...